MARKET

AXDX

AXDX

Accelerate Diagnostics Inc
NASDAQ
0.7558
-0.0042
-0.55%
Opening 12:05 12/07 EST
OPEN
0.7694
PREV CLOSE
0.7600
HIGH
0.7695
LOW
0.7475
VOLUME
44.78K
TURNOVER
28.31K
52 WEEK HIGH
5.59
52 WEEK LOW
0.5020
MARKET CAP
74.90M
P/E (TTM)
-0.7807
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 11/22 13:08
Accelerate Diagnostics Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Accelerate Diagnostics ( NASDAQ:AXDX ) Third Quarter 2022 Results Key Financial Results Revenue: US$2.96m (down 5.2...
Simply Wall St. · 11/16 15:22
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Benzinga · 11/16 10:01
Accelerate Diagnostics falls after missing Q3 revenue consensus, lowering guidance
Seekingalpha · 11/15 18:34
4D Molecular, Azenta top healthcare gainers; Twist Bioscience, Lumos among losers
Seekingalpha · 11/15 15:00
Accelerate Diagnostics Q3 EPS $(0.18) Beats $(0.19) Estimate, Sales $2.96M Miss $3.75M Estimate
Benzinga · 11/14 21:54
BRIEF-Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
Reuters · 11/14 21:41
Accelerate Diagnostics GAAP EPS of -$0.18, revenue of $2.96M
Seekingalpha · 11/14 21:11
More
About AXDX
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.

Webull offers kinds of Accelerate Diagnostics Inc stock information, including NASDAQ:AXDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXDX stock methods without spending real money on the virtual paper trading platform.